Day 1

---

Creating Supply Chain Resilience is more critical than ever before! The “End to End Supply Chain” in a world of over 150 markets, is getting more complex, not easier. The front end is R&D, with the other end being the Consumer or patient, and Manufacturing is everything in between, or they are in the middle. The Supply Chain needs to be able to respond to and be aware of changing governments, customers and payers within all countries.

Global Complexity is created by different time zones, currency, established markets versus Emerging markets. Please think of the differences of doing business in Taiwan versus Russia, or the business differences in countries in Western versus Eastern Europe, or North versus South and Central America! Even how you move products between countries and Regions is changing from Road and Rail to Air and Ocean shipments.

Companies that understand the changes, stay ahead of their competition by Shifting their Product Portfolio. They look at what the end Customer needs and it may be 2 doses a day they can afford to purchase, rather than 4 doses, or 15, 30 or 60. They shift their Product Portfolio because cost and complexity may be more important in some markets or countries around the world than others. They may also choose to focus or make changes from a Brand name to a Generic to allow more Customers to be engaged with their product. “One size does not fit all anymore”.

---

In this LogiPharma USA first, Gary Lanzilotti, VP Supply Chain of Panasonic will bring a fresh perspective to the conference and discuss how supply chains operate in the electronics industry.
This session will cover: • Supply chain management - transforming PNA's consumer sector from a monthly operating pattern focused on "sell in" to a weekly "sell thru" operating pattern based on POS analytics
• Retooling of competencies, processes, systems & business rules
• Standardizing operational processes by customer segments to improve customer service, costing & assisting profitability improvements in consumer, b-2-b, enterprise & Housing & Health care Sectors
• Defining North America Logistics Strategies, Governance & Operations
• Determining how to create a cost to serve model for key customers to determine their profitability

---

In this session, learn how leading pharmaceutical companies are using cloud technology to achieve supply chain excellence across their end-to-end, global value chains. Leaders in the industry have clear visibility into business processes and can rapidly respond to real-time changes when they operate in a scalable, agile and connected environment. Operating as a network is the only way to gain control of business beyond the four walls of the enterprise – and it is the only path to value in today’s complex supply chains.

---

---

In this session, learn how leading pharmaceutical companies are using cloud technology to achieve supply chain excellence across their end-to-end, global value chains. Leaders in the industry have clear visibility into business processes and can rapidly respond to real-time changes when they operate in a scalable, agile and connected environment. Operating as a network is the only way to gain control of business beyond the four walls of the enterprise – and it is the only path to value in today’s complex supply chains.

---

---

---

---

---

---

Nearly fifty countries require notification of drug shortages to their health authorities and many have significant differences between when and what types of products industry needs to report. These requirements continue to evolve with revised and more demanding reporting needs for FDA and EMA, among others, for example.

What do these changes mean to us as an industry and how we are dealing with it in the course of managing our day-to-day business? In this fire-side chat, David Sponseller of Pfizer will discuss how they are trying to tackle the issues.

---

Nearly fifty countries require notification of drug shortages to their health authorities and many have significant differences between when and what types of products industry needs to report. These requirements continue to evolve with revised and more demanding reporting needs for FDA and EMA, among others, for example.

What do these changes mean to us as an industry and how we are dealing with it in the course of managing our day-to-day business? In this fire-side chat, David Sponseller of Pfizer will discuss how they are trying to tackle the issues.

How well do you know your supply chain? Are any tradeoffs required across key supply chain metrics? What drives good performance in pharmaceutical supply chain? This session will answer these questions using live audience polling and by drawing insights from the proprietary research and benchmarking conducted by McKinsey & Company

---

• Role of Safety Stock in an uncertain environment
• Multi-Sourcing: Think turning an Aircraft Carrier
• Cold Chain Logistics: Never take your eye off the ball

---

---

Continuing the discussion on the future of track and trace extending to the consumer through the use of mobile phones, Frequentz brings a case study on how a mobile app can solve today’s supply chain issues including:
• Real-time transportation and logistics (including route or delivery planning)
• Product safety and counterfeit protection
• Value beyond simple regulatory compliance
• Recouping the cost a track and trace solution through financial models inherent in the app
• Increasing brand loyalty and consumer awareness of your product

---

Continuing the discussion on the future of track and trace extending to the consumer through the use of mobile phones, Frequentz brings a case study on how a mobile app can solve today’s supply chain issues including:
• Real-time transportation and logistics (including route or delivery planning)
• Product safety and counterfeit protection
• Value beyond simple regulatory compliance
• Recouping the cost a track and trace solution through financial models inherent in the app
• Increasing brand loyalty and consumer awareness of your product

This panel discussion will focus on the US market, as well as skipping over 2015 deliverables for the DSCSA. It will cover:

• What is the scope of your program? Mfg / CMO sites? Supply chain / logistics? Commercial? External communications? Etc…
• What does your supply network look like?
• What is you data management strategy and how does it link into existing operations/systems?
• Do you need a global or a local program?

---

---

---

---

Sophisticated criminal organizations have been known to steal large quantities of pharmaceutical goods and attempt to re-introduce them back into legitimate supply chains. This type of activity has the potential to put patient safety at risk because improperly maintained pharmaceutical goods, which could be used by unsuspecting patients and/ or healthcare professionals, can be ineffective or perhaps even harmful. There are industry tested and sustained best practices for the security of both the in-transit and storage of pharmaceutical goods which will be discussed in this session:

• Best practices in ensuring integrity of your
product:
-- Temp controls have been maintained
-- The integrity of the package, hasn’t been violated
-- Integrity of expiration date
-- The security of the shipments, no cargo theft

• Examining new technologies that could stop counterfeits coming into the supply chain at any step, to anybody
-- Do we need an app for supply chain security?

• Learn the methods used by these criminal organizations
• Examine several key case studies
• Learn the latest in modern technology used to protect pharmaceutical goods in transit

---

---

---